Alere provides diagnostics and health management solutions. The Company's products and services are focused on infectious disease, cardiology, oncology, drugs of abuse and women's health. Its brands range from over-the-counter tests to lab-based diagnostics to integrated home monitoring solutions. Alere's brands include Acceava Mono cassette, Alere Home Monitoring, AtheNA Multi-Lyte Test System, BinaxNOW, Cholestech LDX, Clearview iFOB Complete, Determine HBsAg, DoubleCheckGold and ImmunoComb.
Company Growth (employees)
Type
Public
HQ
Waltham, US
Founded
1981
Size (employees)
9,700 (est)+6%
Website
alere.com
Alere was founded in 1981 and is headquartered in Waltham, US

Alere Office Locations

Alere has an office in Waltham
Waltham, US (HQ)
200 51 Sawyer Rd
Show all (1)

Alere Financials and Metrics

Alere Financials

Alere's revenue was reported to be $582.3 m in FY, 2016
USD

Revenue (Q2, 2017)

557.7 m

Net income (Q2, 2017)

(92.7 m)

EBIT (Q2, 2017)

(29 m)

Market capitalization (02-Oct-2017)

4.5 b

Cash (30-Jun-2017)

491.7 m

EV

6.8 b
Alere's current market capitalization is $4.5 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

3 b2.6 b2.5 b582.3 m

Revenue growth, %

(15%)(5%)(76%)

Sales and marketing expense

102 m

R&D expense

31.4 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

753.9 m716.6 m737.9 m736.2 m608.2 m629.2 m602 m578.2 m611.1 m582.4 m588.2 m557.7 m

Sales and marketing expense

159.6 m147.1 m150.7 m136.3 m109.1 m107.2 m106.5 m99.8 m102.5 m102 m94.2 m96.2 m

R&D expense

40.5 m38.7 m37.4 m38.7 m28 m27.2 m36 m27.1 m28.4 m31.4 m26.3 m29.4 m

General and administrative expense

142.4 m139.5 m159.9 m130.2 m92.7 m60.8 m101.3 m115 m128.4 m129.3 m166.3 m156 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

361.9 m378.5 m502.2 m567.2 m

Inventories

129.7 m131.6 m152.2 m308.9 m

Current Assets

1.5 b1.8 b1.5 b1.5 b

PP&E

545.2 m456.8 m446 m441.2 m
USDQ3, 2013Q1, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

354 m433 m464.9 m479.4 m490.7 m506.2 m566.2 m601.5 m491.7 m

Inventories

370.4 m371.1 m366.3 m362.2 m350.9 m333.8 m348.8 m322.5 m335.7 m

Current Assets

1.5 b1.5 b1.9 b1.9 b1.5 b1.4 b1.5 b1.5 b1.4 b

PP&E

544.3 m545.1 m448.3 m445.3 m445.2 m438.8 m446.3 m439.8 m436.2 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(70.3 m)9.9 m206.8 m(137.3 m)

Depreciation and Amortization

439.4 m335.8 m309.3 m285.6 m

Accounts Receivable

(36 m)1.3 m(14 m)26.7 m

Inventories

(12 m)(48 m)(43 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(67 m)(6.1 m)(55.7 m)(142.2 m)209.2 m229.5 m235 m(10 m)(44.9 m)(22.8 m)(64.1 m)(92.7 m)

Depreciation and Amortization

326.7 m98.1 m196 m290.8 m74.4 m147 m233.5 m72.5 m142.4 m214.2 m60.9 m62.5 m

Accounts Receivable

(57.3 m)19.9 m13.2 m20.4 m(16.9 m)(27.5 m)(11.3 m)(9.2 m)20 m22.1 m33.1 m

Accounts Payable

16 m5.2 m30.8 m38.3 m(18.6 m)(23.3 m)(16 m)(31.5 m)(1 k)18.5 m13.4 m
Y, 2017

EV/EBIT

-233.8 x

Financial Leverage

3.1 x
Show all financial metrics

Alere Market Value History

Alere Median Salaries

Source: 23 public H-1B filings from Alere

Alere's Web-traffic and Trends

Alere Online and Social Media Presence

Alere News and Updates

Cardiac Biomarker Company Critical Diagnostics Completes $8.5 Million Financing and Announces Two Promotions

PRESS RELEASE: Critical Diagnostics, makers of the Presage® ST2 Assay and ASPECT-PLUSTM ST2 Test, both used to help physicians in the management of heart failure patients, today announced it completed an $8.5 million equity financing from...

POC HbA1C Testing Market 2017 Global Manufactures : PTS Diagnostics, Tosoh Bioscience, Alere and Arkray

Market Research Store added a depth and professional market study report on Global POC HbA1C Testing Market 2017. This report also provides more details about Market Size, Share, Analysis, import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. Posted via Indust…

Alere Company Life and Culture

You may also be interested in